Passive immunotherapy in neonatal calves--I. Safety and potency of a J5 Escherichia coli hyperimmune plasma in neonatal calves

By Selim S.A.   Cullor J.S.   Oelsner I.E.  

Vaccine, Vol. 13, Iss. 15, 1995-01 ,pp. : 1449-1453

Elsevier

Access to resources Recommend Favorite

Passive immunotherapy in neonatal calves--II. The efficacy of a J5 Escherichia coli hyperimmune plasma as immunotherapy in neonatal calves

By Selim S.A.   Holmberg C.A.   Cullor J.S.  

Vaccine, Vol. 13, Iss. 15, 1995-01 ,pp. : 1454-1459

Elsevier

Access to resources Recommend Favorite

The efficacy of modified-live bovine respiratory syncytial virus vaccines in experimentally infected calves

By West K.   Petrie L.   Konoby C.   Haines D.M.   Cortese V.   Ellis J.A.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 907-919

Elsevier

Access to resources Recommend Favorite

Expression of a pilin subunit BfpA of the bundle-forming pilus of enteropathogenic Escherichia coli in an aroA live salmonella vaccine strain

By Schriefer A.   Maltez J.R.   Silva N.   Stoeckle M.Y.   Barral-Netto M.   Riley L.W.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 770-778

Elsevier

Access to resources Recommend Favorite

Rapid onset of protection following vaccination of calves with multivalent vaccines containing modified-live or modified-live and killed BHV-1 is associated with virus-specific interferon gamma production

By Woolums A.R.   Siger L.   Johnson S.   Gallo G.   Conlon J.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1158-1164

Elsevier

Access to resources Recommend Favorite